GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $19.77 and traded as low as $19.32. GENMAB A/S/S shares last traded at $19.65, with a volume of 1,039,385 shares traded.
GENMAB A/S/S Trading Up 1.2%
The stock’s 50 day moving average is $19.77 and its 200 day moving average is $20.72.
About GENMAB A/S/S
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Recommended Stories
- Five stocks we like better than GENMAB A/S/S
- Consumer Discretionary Stocks Explained
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- Canadian Penny Stocks: Can They Make You Rich?
- Savvy Investors Are Raising a Glass for Heineken Stock
- How to Profit From Value Investing
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
